Skip to main content

This site is intended for Healthcare Professionals in the UK and Ireland
Members of the public, please visit: Accu-Chek | mySugr

Accu-Chek FastClix

Accu-Chek FastClix finger pricker

JUST ONE CLICK

Included in all Accu-Chek Instant meter kits, the Accu-Chek FastClix finger pricker provides virtually pain free1 lancing for your patients with diabetes. 

Download quick reference guide

Key benefits

  • Simple: Your patients can prime and release in 1-Click action
  • Gentle: Clixmotion technology enables guided lancet motion, and 11 depth settings to suit individual skin types
  • Unique: 6 lancets contained in a drum - there are no single lancets to see or touch
  • Convenient: Used lancet drums can be disposed of in household waste (unless other regulations apply locally)
Formulary implementation Get product support

Additional specifications

  • Penetration depth setting: 11 setting comfort dial
  • Penetration range: 0.7 to 2.2 mm
  • Prime & release of device: Press once to lance
  • Size of device (length x width): 119 x 19 mm*
  • Weight (including drum): 19.3 g*
  • Environmental needs: Uncritical plastic material, Biocompatible materials, Latex-free
  • AST capability: Yes (with AST cap, available on request)
  • Durability of device: Approximately 5000 finger pricks
  • Lancet gauge: 0,3mm (30g)

 

* Dimensions and weight refer to the standalone Accu-Chek FastClix II. Bundled devices may vary.

Product training & support

How to use the Accu-Chek FastClix lancing device

Learn how to use the Accu-Chek FastClix lancing device.

Related Products & Solutions

1. Jendrike N et al. Pain sensation at Fingertips and Palm by using different Blood Glucose Monitoring Systems. Diabetes Technology Meeting. San Francisco, 5-7 November 2009.

 

Safety advice: The Accu-Chek FastClix finger pricker is intended for patient self-monitoring by an individual person only. It must not be used to collect blood in a multipatient setting as it does not incorporate any features to guard against cross infection.

The use of the Accu-Chek FastClix lancet device and AST cap have not been evaluated in neonates. We do not have any data to support use in this population and are not able to make specific recommendations.

Any decision is the responsibility of the HCP and we recommend they are consulted before initial use in children.

For further information; worldwide guidelines for capillary blood samples differ by age. Depth of lancet setting should be considered carefully according to the age and size of the child. WHO recommends that the heel only be used for capillary blood sampling in newborns and children under 6 months and the posterior aspect of the heel should be avoided due to the risk of hitting bone.